161
views
0
recommends
+1 Recommend
0 collections
    8
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Bone progenitor dysfunction induces myelodysplasia and secondary leukemia

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mesenchymal cell populations contribute to microenvironments regulating stem cells and the growth of malignant cells. Osteolineage cells participate in the hematopoietic stem cell niche. Here, we report that deletion of the miRNA processing endonuclease Dicer1 selectively in mesenchymal osteoprogenitors induces markedly disordered hematopoiesis. Hematopoietic changes affected multiple lineages recapitulating key features of human myelodysplastic syndrome (MDS) including the development of acute myelogenous leukemia. These changes were microenvironment dependent and induced by specific cells in the osteolineage. Dicer1 −/− osteoprogenitors expressed reduced levels of Sbds, the gene mutated in the human bone marrow failure and leukemia predisposition Shwachman-Bodian-Diamond Syndrome. Deletion of Sbds in osteoprogenitors largely phenocopied Dicer1 deletion. These data demonstrate that differentiation stage-specific perturbations in osteolineage cells can induce complex hematological disorders and indicate the central role individual cellular elements of ‘estroma’ can play in tissue homeostasis. They reveal that primary changes in the hematopoietic microenvironment can initiate secondary neoplastic disease.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Impaired microRNA processing enhances cellular transformation and tumorigenesis.

          MicroRNAs (miRNAs) are a new class of small noncoding RNAs that post-transcriptionally regulate the expression of target mRNA transcripts. Many of these target mRNA transcripts are involved in proliferation, differentiation and apoptosis, processes commonly altered during tumorigenesis. Recent work has shown a global decrease of mature miRNA expression in human cancers. However, it is unclear whether this global repression of miRNAs reflects the undifferentiated state of tumors or causally contributes to the transformed phenotype. Here we show that global repression of miRNA maturation promotes cellular transformation and tumorigenesis. Cancer cells expressing short hairpin RNAs (shRNAs) targeting three different components of the miRNA processing machinery showed a substantial decrease in steady-state miRNA levels and a more pronounced transformed phenotype. In animals, miRNA processing-impaired cells formed tumors with accelerated kinetics. These tumors were more invasive than control tumors, suggesting that global miRNA loss enhances tumorigenesis. Furthermore, conditional deletion of Dicer1 enhanced tumor development in a K-Ras-induced mouse model of lung cancer. Overall, these studies indicate that abrogation of global miRNA processing promotes tumorigenesis.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A paracrine requirement for hedgehog signalling in cancer.

            Ligand-dependent activation of the hedgehog (Hh) signalling pathway has been associated with tumorigenesis in a number of human tissues. Here we show that, although previous reports have described a cell-autonomous role for Hh signalling in these tumours, Hh ligands fail to activate signalling in tumour epithelial cells. In contrast, our data support ligand-dependent activation of the Hh pathway in the stromal microenvironment. Specific inhibition of Hh signalling using small molecule inhibitors, a neutralizing anti-Hh antibody or genetic deletion of smoothened (Smo) in the mouse stroma results in growth inhibition in xenograft tumour models. Taken together, these studies demonstrate a paracrine requirement for Hh ligand signalling in the tumorigenesis of Hh-expressing cancers and have important implications for the development of Hh pathway antagonists in cancer.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche.

              Stem cells reside in a specialized, regulatory environment termed the niche that dictates how they generate, maintain and repair tissues. We have previously documented that transplanted haematopoietic stem and progenitor cell populations localize to subdomains of bone-marrow microvessels where the chemokine CXCL12 is particularly abundant. Using a combination of high-resolution confocal microscopy and two-photon video imaging of individual haematopoietic cells in the calvarium bone marrow of living mice over time, we examine the relationship of haematopoietic stem and progenitor cells to blood vessels, osteoblasts and endosteal surface as they home and engraft in irradiated and c-Kit-receptor-deficient recipient mice. Osteoblasts were enmeshed in microvessels and relative positioning of stem/progenitor cells within this complex tissue was nonrandom and dynamic. Both cell autonomous and non-autonomous factors influenced primitive cell localization. Different haematopoietic cell subsets localized to distinct locations according to the stage of differentiation. When physiological challenges drove either engraftment or expansion, bone-marrow stem/progenitor cells assumed positions in close proximity to bone and osteoblasts. Our analysis permits observing in real time, at a single cell level, processes that previously have been studied only by their long-term outcome at the organismal level.
                Bookmark

                Author and article information

                Journal
                0410462
                6011
                Nature
                Nature
                Nature
                0028-0836
                1476-4687
                25 June 2012
                21 March 2010
                8 April 2010
                20 August 2012
                : 464
                : 7290
                : 852-857
                Affiliations
                [1 ]Center for Regenerative Medicine, Massachusetts General Hospital and Harvard Medical School CPZN - Room 4265A, 185 Cambridge Street, Boston, MA 02114
                [2 ]Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138
                [3 ]Harvard Stem Cell Institute, Cambridge MA 02138
                [4 ]Cancer Center, Massachusetts General Hospital, Boston MA 02114
                [5 ]Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114
                [6 ]Hematology Division, Brigham and Women’s Hospital, Boston MA 02115 and Broad Institute, Cambridge, MA 02138
                [7 ]Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114
                [8 ]Lymphocyte Development Group, Medical Research Council Clinical Sciences Centre, Imperial College London, Du Cane Road, London W12 0NN, United Kingdom
                [9 ]Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114
                [10 ]Program in Genetics and Genome Biology, The Hospital for Sick Children, Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
                Author notes
                Address correspondence to: Marc H.G.P. Raaijmakers, 185 Cambridge Street, Boston, Massachusetts 02114, USA, hraaijmakers@ 123456partners.org or David T. Scadden, 185 Cambridge Street, Boston, Massachusetts 02114, USA. dscadden@ 123456mgh.harvard.edu
                [*]

                These authors contributed equally to this work.

                [#]

                Current address: Department of Medicine and Irving Cancer Research Center, Columbia University School of Medicine, New York 10032

                Article
                nihpa171766
                10.1038/nature08851
                3422863
                20305640
                eb826bd5-9283-4a70-bfb3-5483c9c6ab5e

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Funding
                Funded by: National Heart, Lung, and Blood Institute : NHLBI
                Award ID: U54 HL081030 || HL
                Funded by: National Heart, Lung, and Blood Institute : NHLBI
                Award ID: U01 HL100402 || HL
                Funded by: National Heart, Lung, and Blood Institute : NHLBI
                Award ID: R01 HL097794 || HL
                Funded by: National Heart, Lung, and Blood Institute : NHLBI
                Award ID: R01 HL044851 || HL
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases : NIDDK
                Award ID: R01 DK050234 || DK
                Categories
                Article

                Uncategorized
                Uncategorized

                Comments

                Comment on this article